Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Chang, Jeffrey S ^a   Tsai, Chia Rung ^a   Chen, Li Tzong ^a,b,c,d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BILE DUCT CARCINOMA; CANCER RISK; CHOLANGITIS; CHOLECYSTITIS; CHOLELITHIASIS; CHRONIC NONALCOHOLIC LIVER DISEASE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DIABETES MELLITUS; ENTERITIS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TAIWAN;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGAN SPECIFICITY; RISK FACTORS; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84880656950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069981     Document Type: Article

References (49)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD, (2005) Cholangiocarcinoma. Lancet 366: 1303-1314.
2. Tyson GL, El-Serag HB, (2011) Risk factors of cholangiocarcinoma Hepatology. 54: 173-184.
3. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5: 1221-1228.
4. Szklo M, Nieto FJ (2000) Epidemiology: Beyond the Basicas. Gaithersburg, Maryland: Aspen Publishers, Inc.
5. Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, et al. (2007) Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer 120: 638-641.
6. Ponsioen CY, Vrouenraets SM, Prawirodirdjo W, Rajaram R, Rauws EA, et al. (2002) Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 51: 562-566.
7. Morris-Stiff G, Bhati C, Olliff S, Hubscher S, Gunson B, et al. (2008) Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience. Dig Surg 25: 126-132.
8. Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, et al. (2002) Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 37: 1205-1211.
9. Grainge MJ, West J, Solaymani-Dodaran M, Aithal GP, Card TR, (2009) The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer 100: 178-180.
10. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA, (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128: 620-626.
11. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, et al. (2007) Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 97: 1577-1582.
12. Su CH, Lui WY, P'Eng F K, (1992) Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study. Dig Dis Sci 37: 764-768.
13. Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, et al. (2001) Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 12: 959-964.
14. Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, et al. (2008) Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 14: 632-635.
15. Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, et al. (2009) Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 100: 1765-1770.
16. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, et al. (2008) Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 103: 1716-1720.
17. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 102: 1016-1021.
18. Peng NF, Li LQ, Qin X, Guo Y, Peng T, et al. (2011) Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus. Ann Surg Oncol 18: 1258-1266.
19. Zhou H, Wang H, Zhou D, Wang H, Wang Q, et al. (2010) Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer 46: 1056-1061.
20. Tanaka M, Tanaka H, Tsukuma H, Ioka A, Oshima A, et al. (2009) Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. J Viral Hepat 17: 742-748.
21. Fwu CW, Chien YC, You SL, Nelson KE, Kirk GD, et al. (2011) Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan. Hepatology 53: 1217-1225.
22. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, et al. (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 25: 933-940.
23. Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, et al. (2004) Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 95: 592-595.
24. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, et al. (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology 49: 116-123.
25. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, et al. (2008) Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 122: 1849-1853.
26. Tao LY, He XD, Qu Q, Cai L, Liu W, et al. (2009) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int 30: 215-221.
27. Cai WK, Sima H, Chen BD, Yang GS, (2011) Risk factors for hilar cholangiocarcinoma: a case-control study in China. World J Gastroenterol 17: 249-253.
28. Li M, Li J, Li P, Li H, Su T, et al. (2012) Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review. J Gastroenterol Hepatol 27: 1561-1568.
29. Palmer WC, Patel T, (2012) Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 57: 69-76.
30. Nava S, Westgren M, Jaksch M, Tibell A, Broome U, et al. (2005) Characterization of cells in the developing human liver. Differentiation 73: 249-260.
31. Wu Q, He XD, Yu L, Liu W, Tao LY, (2012) The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China. Asian Pac J Cancer Prev 13: 1963-1969.
32. Shebl FM, Andreotti G, Rashid A, Gao YT, Yu K, et al. (2010) Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer 103: 115-119.
33. Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, et al. (2013) Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology 57: 648-655.
34. De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, et al. (1997) Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 25: 787-790.
35. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, et al. (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60: 207-221.
36. Hsing AW, Sakoda LC, Rashid A, Chen J, Shen MC, et al. (2008) Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 99: 811-815.
37. Parsi MA, (2013) Obesity and cholangiocarcinoma. World J Gastroenterol 19: 457-462.
38. Malfertheiner P, Chan FK, McColl KE, (2009) Peptic ulcer disease. Lancet 374: 1449-1461.
39. Bulajic M, Maisonneuve P, Schneider-Brachert W, Muller P, Reischl U, et al. (2002) Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 95: 1946-1953.
40. Pandey M, Shukla M, (2009) Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers. Surg Oncol 18: 51-56.
41. Saich R, Chapman R, (2008) Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol 14: 331-337.
42. Parente F, Pastore L, Bargiggia S, Cucino C, Greco S, et al. (2007) Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study. Hepatology 45: 1267-1274.
43. Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, et al. (2010) Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 42: 253-260.
44. Vijungco JD, Prinz RA, (2003) Management of biliary and duodenal complications of chronic pancreatitis. World J Surg 27: 1258-1270.
45. Novacek G, (2006) Gender and gallstone disease. Wien Med Wochenschr 156: 527-533.
46. Park SK, Andreotti G, Rashid A, Chen J, Rosenberg PS, et al. (2010) Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Carcinogenesis 31: 842-846.
47. Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, et al. (2001) Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 93: 1644-1651.
48. Tseng TS, Lin HY, (2008) Gender and age disparity in health-related behaviors and behavioral patterns based on a National Survey of Taiwan. Int J Behav Med 15: 14-20.
49. Andreotti G, Chen J, Gao YT, Rashid A, Chen BE, et al. (2008) Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev 17: 525-534.